US Patent 9962344 Chemosensory receptor ligand-based therapies
Patent 9962344 was granted and assigned to Elcelyx Therapeutics Inc. on May, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9962344 Chemosensory receptor ligand-based therapies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
